The global market for NGS Tumor Gene Analysis Software was valued at US$ 2043 million in the year 2024 and is projected to reach a revised size of US$ 6223 million by 2031, growing at a CAGR of 17.5% during the forecast period.

NGS Tumor Gene Analysis Software Market

NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.

North American market for NGS Tumor Gene Analysis Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for NGS Tumor Gene Analysis Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for NGS Tumor Gene Analysis Software in Hospitals and Health Systems is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of NGS Tumor Gene Analysis Software include Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, GTH.O, Golden Helix, Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for NGS Tumor Gene Analysis Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS Tumor Gene Analysis Software.

The NGS Tumor Gene Analysis Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NGS Tumor Gene Analysis Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NGS Tumor Gene Analysis Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of NGS Tumor Gene Analysis Software Market Report

Report Metric	Details
Report Name	NGS Tumor Gene Analysis Software Market
Accounted market size in year	US$ 2043 million
Forecasted market size in 2031	US$ 6223 million
CAGR	17.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Non-Small Cell Lung Cancer Human 6 Gene Mutations Human 12 Gene Mutations Other
Segment by Application	Hospitals and Health Systems Research Institute Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, GTH.O, Golden Helix, Inc, Diatech Pharmacogenetics, ViennaLab Diagnostics GmbH, 3D Medicines
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NGS Tumor Gene Analysis Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is NGS Tumor Gene Analysis Software Market growing?

Ans: The NGS Tumor Gene Analysis Software Market witnessing a CAGR of 17.5% during the forecast period 2025-2031.

What is the NGS Tumor Gene Analysis Software Market size in 2031?

Ans: The NGS Tumor Gene Analysis Software Market size in 2031 will be US$ 6223 million.

Who are the main players in the NGS Tumor Gene Analysis Software Market report?

Ans: The main players in the NGS Tumor Gene Analysis Software Market are Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, GTH.O, Golden Helix, Inc, Diatech Pharmacogenetics, ViennaLab Diagnostics GmbH, 3D Medicines

What are the Application segmentation covered in the NGS Tumor Gene Analysis Software Market report?

Ans: The Applications covered in the NGS Tumor Gene Analysis Software Market report are Hospitals and Health Systems, Research Institute, Other

What are the Type segmentation covered in the NGS Tumor Gene Analysis Software Market report?

Ans: The Types covered in the NGS Tumor Gene Analysis Software Market report are Non-Small Cell Lung Cancer, Human 6 Gene Mutations, Human 12 Gene Mutations, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Non-Small Cell Lung Cancer

1.2.3 Human 6 Gene Mutations

1.2.4 Human 12 Gene Mutations

1.2.5 Other

1.3 Market by Application

1.3.1 Global NGS Tumor Gene Analysis Software Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals and Health Systems

1.3.3 Research Institute

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global NGS Tumor Gene Analysis Software Market Perspective (2020-2031)

2.2 Global NGS Tumor Gene Analysis Software Growth Trends by Region

2.2.1 Global NGS Tumor Gene Analysis Software Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 NGS Tumor Gene Analysis Software Historic Market Size by Region (2020-2025)

2.2.3 NGS Tumor Gene Analysis Software Forecasted Market Size by Region (2026-2031)

2.3 NGS Tumor Gene Analysis Software Market Dynamics

2.3.1 NGS Tumor Gene Analysis Software Industry Trends

2.3.2 NGS Tumor Gene Analysis Software Market Drivers

2.3.3 NGS Tumor Gene Analysis Software Market Challenges

2.3.4 NGS Tumor Gene Analysis Software Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NGS Tumor Gene Analysis Software Players by Revenue

3.1.1 Global Top NGS Tumor Gene Analysis Software Players by Revenue (2020-2025)

3.1.2 Global NGS Tumor Gene Analysis Software Revenue Market Share by Players (2020-2025)

3.2 Global NGS Tumor Gene Analysis Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by NGS Tumor Gene Analysis Software Revenue

3.4 Global NGS Tumor Gene Analysis Software Market Concentration Ratio

3.4.1 Global NGS Tumor Gene Analysis Software Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NGS Tumor Gene Analysis Software Revenue in 2024

3.5 Global Key Players of NGS Tumor Gene Analysis Software Head office and Area Served

3.6 Global Key Players of NGS Tumor Gene Analysis Software, Product and Application

3.7 Global Key Players of NGS Tumor Gene Analysis Software, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 NGS Tumor Gene Analysis Software Breakdown Data by Type

4.1 Global NGS Tumor Gene Analysis Software Historic Market Size by Type (2020-2025)

4.2 Global NGS Tumor Gene Analysis Software Forecasted Market Size by Type (2026-2031)

5 NGS Tumor Gene Analysis Software Breakdown Data by Application

5.1 Global NGS Tumor Gene Analysis Software Historic Market Size by Application (2020-2025)

5.2 Global NGS Tumor Gene Analysis Software Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America NGS Tumor Gene Analysis Software Market Size (2020-2031)

6.2 North America NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America NGS Tumor Gene Analysis Software Market Size by Country (2020-2025)

6.4 North America NGS Tumor Gene Analysis Software Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NGS Tumor Gene Analysis Software Market Size (2020-2031)

7.2 Europe NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe NGS Tumor Gene Analysis Software Market Size by Country (2020-2025)

7.4 Europe NGS Tumor Gene Analysis Software Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NGS Tumor Gene Analysis Software Market Size (2020-2031)

8.2 Asia-Pacific NGS Tumor Gene Analysis Software Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region (2020-2025)

8.4 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America NGS Tumor Gene Analysis Software Market Size (2020-2031)

9.2 Latin America NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America NGS Tumor Gene Analysis Software Market Size by Country (2020-2025)

9.4 Latin America NGS Tumor Gene Analysis Software Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NGS Tumor Gene Analysis Software Market Size (2020-2031)

10.2 Middle East & Africa NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2020-2025)

10.4 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche NGS Tumor Gene Analysis Software Introduction

11.1.4 Roche Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Illumina

11.2.1 Illumina Company Details

11.2.2 Illumina Business Overview

11.2.3 Illumina NGS Tumor Gene Analysis Software Introduction

11.2.4 Illumina Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.2.5 Illumina Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Introduction

11.3.4 Thermo Fisher Scientific Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 BGI Group

11.4.1 BGI Group Company Details

11.4.2 BGI Group Business Overview

11.4.3 BGI Group NGS Tumor Gene Analysis Software Introduction

11.4.4 BGI Group Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.4.5 BGI Group Recent Development

11.5 Novogene

11.5.1 Novogene Company Details

11.5.2 Novogene Business Overview

11.5.3 Novogene NGS Tumor Gene Analysis Software Introduction

11.5.4 Novogene Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.5.5 Novogene Recent Development

11.6 Geneseeq

11.6.1 Geneseeq Company Details

11.6.2 Geneseeq Business Overview

11.6.3 Geneseeq NGS Tumor Gene Analysis Software Introduction

11.6.4 Geneseeq Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.6.5 Geneseeq Recent Development

11.7 AmoyDx

11.7.1 AmoyDx Company Details

11.7.2 AmoyDx Business Overview

11.7.3 AmoyDx NGS Tumor Gene Analysis Software Introduction

11.7.4 AmoyDx Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.7.5 AmoyDx Recent Development

11.8 Burning Rock Medicine

11.8.1 Burning Rock Medicine Company Details

11.8.2 Burning Rock Medicine Business Overview

11.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Introduction

11.8.4 Burning Rock Medicine Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.8.5 Burning Rock Medicine Recent Development

11.9 GTH.O

11.9.1 GTH.O Company Details

11.9.2 GTH.O Business Overview

11.9.3 GTH.O NGS Tumor Gene Analysis Software Introduction

11.9.4 GTH.O Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.9.5 GTH.O Recent Development

11.10 Golden Helix, Inc

11.10.1 Golden Helix, Inc Company Details

11.10.2 Golden Helix, Inc Business Overview

11.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Introduction

11.10.4 Golden Helix, Inc Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.10.5 Golden Helix, Inc Recent Development

11.11 Diatech Pharmacogenetics

11.11.1 Diatech Pharmacogenetics Company Details

11.11.2 Diatech Pharmacogenetics Business Overview

11.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Introduction

11.11.4 Diatech Pharmacogenetics Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.11.5 Diatech Pharmacogenetics Recent Development

11.12 ViennaLab Diagnostics GmbH

11.12.1 ViennaLab Diagnostics GmbH Company Details

11.12.2 ViennaLab Diagnostics GmbH Business Overview

11.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Introduction

11.12.4 ViennaLab Diagnostics GmbH Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.12.5 ViennaLab Diagnostics GmbH Recent Development

11.13 3D Medicines

11.13.1 3D Medicines Company Details

11.13.2 3D Medicines Business Overview

11.13.3 3D Medicines NGS Tumor Gene Analysis Software Introduction

11.13.4 3D Medicines Revenue in NGS Tumor Gene Analysis Software Business (2020-2025)

11.13.5 3D Medicines Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Illumina Inc

Thermo Fisher Scientific

Burning Rock Medicine

GTH.O

Golden Helix, Inc.

3D Medicines

Diatech Pharmacogenetics

ViennaLab Diagnostics GmbH

List of Tables

Table 1. Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Non-Small Cell Lung Cancer

Table 3. Key Players of Human 6 Gene Mutations

Table 4. Key Players of Human 12 Gene Mutations

Table 5. Key Players of Other

Table 6. Global NGS Tumor Gene Analysis Software Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global NGS Tumor Gene Analysis Software Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global NGS Tumor Gene Analysis Software Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global NGS Tumor Gene Analysis Software Market Share by Region (2020-2025)

Table 10. Global NGS Tumor Gene Analysis Software Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global NGS Tumor Gene Analysis Software Market Share by Region (2026-2031)

Table 12. NGS Tumor Gene Analysis Software Market Trends

Table 13. NGS Tumor Gene Analysis Software Market Drivers

Table 14. NGS Tumor Gene Analysis Software Market Challenges

Table 15. NGS Tumor Gene Analysis Software Market Restraints

Table 16. Global NGS Tumor Gene Analysis Software Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global NGS Tumor Gene Analysis Software Market Share by Players (2020-2025)

Table 18. Global Top NGS Tumor Gene Analysis Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Tumor Gene Analysis Software as of 2024)

Table 19. Ranking of Global Top NGS Tumor Gene Analysis Software Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by NGS Tumor Gene Analysis Software Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of NGS Tumor Gene Analysis Software, Headquarters and Area Served

Table 22. Global Key Players of NGS Tumor Gene Analysis Software, Product and Application

Table 23. Global Key Players of NGS Tumor Gene Analysis Software, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global NGS Tumor Gene Analysis Software Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global NGS Tumor Gene Analysis Software Revenue Market Share by Type (2020-2025)

Table 27. Global NGS Tumor Gene Analysis Software Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global NGS Tumor Gene Analysis Software Revenue Market Share by Type (2026-2031)

Table 29. Global NGS Tumor Gene Analysis Software Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global NGS Tumor Gene Analysis Software Revenue Market Share by Application (2020-2025)

Table 31. Global NGS Tumor Gene Analysis Software Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global NGS Tumor Gene Analysis Software Revenue Market Share by Application (2026-2031)

Table 33. North America NGS Tumor Gene Analysis Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America NGS Tumor Gene Analysis Software Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America NGS Tumor Gene Analysis Software Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe NGS Tumor Gene Analysis Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe NGS Tumor Gene Analysis Software Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe NGS Tumor Gene Analysis Software Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific NGS Tumor Gene Analysis Software Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America NGS Tumor Gene Analysis Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America NGS Tumor Gene Analysis Software Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America NGS Tumor Gene Analysis Software Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa NGS Tumor Gene Analysis Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2026-2031) & (US$ Million)

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche NGS Tumor Gene Analysis Software Product

Table 51. Roche Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Illumina Company Details

Table 54. Illumina Business Overview

Table 55. Illumina NGS Tumor Gene Analysis Software Product

Table 56. Illumina Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 57. Illumina Recent Development

Table 58. Thermo Fisher Scientific Company Details

Table 59. Thermo Fisher Scientific Business Overview

Table 60. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product

Table 61. Thermo Fisher Scientific Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 62. Thermo Fisher Scientific Recent Development

Table 63. BGI Group Company Details

Table 64. BGI Group Business Overview

Table 65. BGI Group NGS Tumor Gene Analysis Software Product

Table 66. BGI Group Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 67. BGI Group Recent Development

Table 68. Novogene Company Details

Table 69. Novogene Business Overview

Table 70. Novogene NGS Tumor Gene Analysis Software Product

Table 71. Novogene Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 72. Novogene Recent Development

Table 73. Geneseeq Company Details

Table 74. Geneseeq Business Overview

Table 75. Geneseeq NGS Tumor Gene Analysis Software Product

Table 76. Geneseeq Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 77. Geneseeq Recent Development

Table 78. AmoyDx Company Details

Table 79. AmoyDx Business Overview

Table 80. AmoyDx NGS Tumor Gene Analysis Software Product

Table 81. AmoyDx Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 82. AmoyDx Recent Development

Table 83. Burning Rock Medicine Company Details

Table 84. Burning Rock Medicine Business Overview

Table 85. Burning Rock Medicine NGS Tumor Gene Analysis Software Product

Table 86. Burning Rock Medicine Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 87. Burning Rock Medicine Recent Development

Table 88. GTH.O Company Details

Table 89. GTH.O Business Overview

Table 90. GTH.O NGS Tumor Gene Analysis Software Product

Table 91. GTH.O Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 92. GTH.O Recent Development

Table 93. Golden Helix, Inc Company Details

Table 94. Golden Helix, Inc Business Overview

Table 95. Golden Helix, Inc NGS Tumor Gene Analysis Software Product

Table 96. Golden Helix, Inc Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 97. Golden Helix, Inc Recent Development

Table 98. Diatech Pharmacogenetics Company Details

Table 99. Diatech Pharmacogenetics Business Overview

Table 100. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product

Table 101. Diatech Pharmacogenetics Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 102. Diatech Pharmacogenetics Recent Development

Table 103. ViennaLab Diagnostics GmbH Company Details

Table 104. ViennaLab Diagnostics GmbH Business Overview

Table 105. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product

Table 106. ViennaLab Diagnostics GmbH Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 107. ViennaLab Diagnostics GmbH Recent Development

Table 108. 3D Medicines Company Details

Table 109. 3D Medicines Business Overview

Table 110. 3D Medicines NGS Tumor Gene Analysis Software Product

Table 111. 3D Medicines Revenue in NGS Tumor Gene Analysis Software Business (2020-2025) & (US$ Million)

Table 112. 3D Medicines Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. NGS Tumor Gene Analysis Software Picture

Figure 2. Global NGS Tumor Gene Analysis Software Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global NGS Tumor Gene Analysis Software Market Share by Type: 2024 VS 2031

Figure 4. Non-Small Cell Lung Cancer Features

Figure 5. Human 6 Gene Mutations Features

Figure 6. Human 12 Gene Mutations Features

Figure 7. Other Features

Figure 8. Global NGS Tumor Gene Analysis Software Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global NGS Tumor Gene Analysis Software Market Share by Application: 2024 VS 2031

Figure 10. Hospitals and Health Systems Case Studies

Figure 11. Research Institute Case Studies

Figure 12. Other Case Studies

Figure 13. NGS Tumor Gene Analysis Software Report Years Considered

Figure 14. Global NGS Tumor Gene Analysis Software Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global NGS Tumor Gene Analysis Software Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global NGS Tumor Gene Analysis Software Market Share by Region: 2024 VS 2031

Figure 17. Global NGS Tumor Gene Analysis Software Market Share by Players in 2024

Figure 18. Global Top NGS Tumor Gene Analysis Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Tumor Gene Analysis Software as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by NGS Tumor Gene Analysis Software Revenue in 2024

Figure 20. North America NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America NGS Tumor Gene Analysis Software Market Share by Country (2020-2031)

Figure 22. United States NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe NGS Tumor Gene Analysis Software Market Share by Country (2020-2031)

Figure 26. Germany NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific NGS Tumor Gene Analysis Software Market Share by Region (2020-2031)

Figure 34. China NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America NGS Tumor Gene Analysis Software Market Share by Country (2020-2031)

Figure 42. Mexico NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa NGS Tumor Gene Analysis Software Market Share by Country (2020-2031)

Figure 46. Turkey NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE NGS Tumor Gene Analysis Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Roche Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 50. Illumina Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 52. BGI Group Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 53. Novogene Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 54. Geneseeq Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 55. AmoyDx Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 56. Burning Rock Medicine Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 57. GTH.O Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 58. Golden Helix, Inc Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 59. Diatech Pharmacogenetics Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 60. ViennaLab Diagnostics GmbH Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 61. 3D Medicines Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25S19602

Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Mine Schedule Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14P19942

Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Mine Survey Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-1N19842

Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Cotton ERP System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6T20027

Tue Sep 16 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global NGS Tumor Gene Analysis Software Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-1U15180

Global NGS Tumor Gene Analysis Software Market Research Report 2025

FEATURED COMPANIES

NGS Tumor Gene Analysis Software Market Size

NGS Tumor Gene Analysis Software Market

Scope of NGS Tumor Gene Analysis Software Market Report

Chapter Outline

FAQ for this report

How fast is NGS Tumor Gene Analysis Software Market growing?

What is the NGS Tumor Gene Analysis Software Market size in 2031?

Who are the main players in the NGS Tumor Gene Analysis Software Market report?

What are the Application segmentation covered in the NGS Tumor Gene Analysis Software Market report?

What are the Type segmentation covered in the NGS Tumor Gene Analysis Software Market report?

FEATURED COMPANIES

RELATED REPORTS